Related content

Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients

By Kebapcilar Levent   Kebapcilar Ayse Gul   Bilgir Oktay   Taner Cuneyt Eftal   Bozkaya Giray   Yildiz Yasar   Sari Ismail  

Gynecological Endocrinology, Vol. 27, Iss. 2, 2011-02 ,pp. : 91-95

Informa Healthcare

Access to resources Recommend Favorite

Changes in hemostatic parameters after oral and transdermal hormone therapy in postmenopausal women

By Polac Ireneusz   Borowiecka Marta   Wilamowska Agnieszka   Bijak Michal   Ponczek Michal B.   Nowak Pawel  

Gynecological Endocrinology, Vol. 27, Iss. 9, 2011-09 ,pp. : 692-695

Informa Healthcare

Access to resources Recommend Favorite

Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets

By Reinboldt Stephan   Wenzel Folker   Rauch Bernhard   Hohlfeld Thomas   Grandoch Maria   Fischer Jens   Weber Artur-Aron  

Platelets, Vol. 20, Iss. 6, 2009-09 ,pp. : 441-444

Informa Healthcare

Access to resources Recommend Favorite

Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women

By García-Pérez Miguel   Moreno-Mercer Jane   Tarín Juan   Cano Antonio  

Gynecological Endocrinology, Vol. 22, Iss. 4, 2006-04 ,pp. : 179-184

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women

By Dansuk R   Unal O   Karageyim Y   Esim E   Turan C  

Gynecological Endocrinology, Vol. 18, Iss. 5, 2004-05 ,pp. : 233-239

Informa Healthcare

Access to resources Recommend Favorite